Literature DB >> 33970542

Antimicrobial properties of Lactobacillus cell-free supernatants against multidrug-resistant urogenital pathogens.

Marina Scillato1, Ambra Spitale1, Gino Mongelli1, Grete Francesca Privitera1, Katia Mangano2, Antonio Cianci3, Stefania Stefani1, Maria Santagati1.   

Abstract

The healthy vaginal microbiota is dominated by Lactobacillus spp., which provide an important critical line of defense against pathogens, as well as giving beneficial effects to the host. We characterized L. gasseri 1A-TV, L. fermentum 18A-TV, and L. crispatus 35A-TV, from the vaginal microbiota of healthy premenopausal women, for their potential probiotic activities. The antimicrobial effects of the 3 strains and their combination against clinical urogenital bacteria were evaluated together with the activities of their metabolites produced by cell-free supernatants (CFSs). Their beneficial properties in terms of ability to interfere with vaginal pathogens (co-aggregation, adhesion to HeLa cells, biofilm formation) and antimicrobial activity mediated by CFSs were assessed against multidrug urogenital pathogens (S. agalactiae, E. coli, KPC-producing K. pneumoniae, S. aureus, E. faecium VRE, E. faecalis, P. aeruginosa, P. mirabilis, P. vulgaris, C. albicans, C. glabrata). The Lactobacilli tested exhibited an extraordinary ability to interfere and co-aggregate with urogenital pathogens, except for Candida spp., as well as to adhere to HeLa cells and to produce biofilm in the Lactobacillus combination. Lactobacillus CFSs and their combination revealed a strong bactericidal effect on the multidrug resistant indicator strains tested, except for E. faecium and E. faecalis. The antimicrobial activity was maintained after heat treatment but decreased after enzymatic treatment. All Lactobacilli showed lactic dehydrogenase activity and production of D- and L-lactic acid isomers on Lactobacillus CFSs, while only 1A-TV and 35A-TV released hydrogen peroxide and carried helveticin J and acidocin A bacteriocins. These results suggest that they can be employed as a new vaginal probiotic formulation and bio-therapeutic preparation against urogenital infections. Further, in vivo studies are needed to evaluate human health benefits in clinical situations.
© 2021 The Authors. MicrobiologyOpen published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Lactobacilli; MDR-urogenital infection; antimicrobial activity; supernatants; vaginal probiotics

Year:  2021        PMID: 33970542     DOI: 10.1002/mbo3.1173

Source DB:  PubMed          Journal:  Microbiologyopen        ISSN: 2045-8827            Impact factor:   3.139


  5 in total

1.  Intrinsically High Resistance of Candida glabrata to Hydrogen Peroxide and Its Reversal in a Fluconazole-Resistant Mutant.

Authors:  Tom Edlind; Santosh Katiyar
Journal:  Antimicrob Agents Chemother       Date:  2022-08-02       Impact factor: 5.938

2.  Genome mining reveals polysaccharide-degrading potential and new antimicrobial gene clusters of novel intestinal bacterium Paenibacillus jilinensis sp. nov.

Authors:  Ke Ma; Wei Chen; Shi-Qing Yan; Xiao-Qi Lin; Zhen-Zhen Liu; Jia-Bao Zhang; Yu Gao; Yong-Jun Yang
Journal:  BMC Genomics       Date:  2022-05-19       Impact factor: 4.547

3.  Clustering Analysis of the Multi-Microbial Consortium by Lactobacillus Species Against Vaginal Dysbiosis Among Ecuadorian Women.

Authors:  David Pacha-Herrera; Maria P Erazo-Garcia; Darío F Cueva; Miguel Orellana; Pamela Borja-Serrano; Camila Arboleda; Eduardo Tejera; António Machado
Journal:  Front Cell Infect Microbiol       Date:  2022-05-11       Impact factor: 6.073

4.  Genomic insights into Lactobacillus gasseri and Lactobacillus paragasseri.

Authors:  Adriana Ene; Natalie Stegman; Alan Wolfe; Catherine Putonti
Journal:  PeerJ       Date:  2022-06-07       Impact factor: 3.061

Review 5.  Insights From the Lactobacillus johnsonii Genome Suggest the Production of Metabolites With Antibiofilm Activity Against the Pathobiont Candida albicans.

Authors:  Roberto Vazquez-Munoz; Angela Thompson; Jordan T Russell; Takanori Sobue; Yanjiao Zhou; Anna Dongari-Bagtzoglou
Journal:  Front Microbiol       Date:  2022-03-07       Impact factor: 5.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.